These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 16849551
1. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Kern MA, Haugg AM, Koch AF, Schilling T, Breuhahn K, Walczak H, Fleischer B, Trautwein C, Michalski C, Schulze-Bergkamen H, Friess H, Stremmel W, Krammer PH, Schirmacher P, Müller M. Cancer Res; 2006 Jul 15; 66(14):7059-66. PubMed ID: 16849551 [Abstract] [Full Text] [Related]
2. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T. Int J Mol Med; 2006 Jul 15; 18(1):41-7. PubMed ID: 16786154 [Abstract] [Full Text] [Related]
3. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. J Natl Cancer Inst; 2004 Dec 01; 96(23):1769-80. PubMed ID: 15572759 [Abstract] [Full Text] [Related]
7. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D. Mol Carcinog; 2009 Jan 01; 48(1):56-65. PubMed ID: 18506760 [Abstract] [Full Text] [Related]
13. Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells. Pan YY, Xu SP, Jia XY, Xu HQ, Zhang Y, Rui LX, Wei W. Exp Oncol; 2007 Mar 15; 29(1):23-9. PubMed ID: 17431384 [Abstract] [Full Text] [Related]
14. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A, Castle VP, Bouziane M, Bhalla K, Haldar S. Cancer Res; 2006 Apr 15; 66(8):4309-18. PubMed ID: 16618756 [Abstract] [Full Text] [Related]
15. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer PH, Galle PR. BMC Cancer; 2006 Oct 02; 6():232. PubMed ID: 17014711 [Abstract] [Full Text] [Related]
16. Synergistic effect of celecoxib on TRAIL-induced apoptosis in hepatocellular carcinoma cells. Lu G, Liu Y, Ji B, Wei F, Hao C, Wang G. Cancer Invest; 2010 Jul 02; 28(6):629-34. PubMed ID: 20394499 [Abstract] [Full Text] [Related]
18. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM. J Gastroenterol Hepatol; 2009 Mar 02; 24(3):443-52. PubMed ID: 19226377 [Abstract] [Full Text] [Related]
19. Celecoxib activates a novel mitochondrial apoptosis signaling pathway. Jendrossek V, Handrick R, Belka C. FASEB J; 2003 Aug 02; 17(11):1547-9. PubMed ID: 12824303 [Abstract] [Full Text] [Related]
20. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma. Shiraki K, Yamanaka T, Inoue H, Kawakita T, Enokimura N, Okano H, Sugimoto K, Murata K, Nakano T. Int J Oncol; 2005 May 02; 26(5):1273-81. PubMed ID: 15809718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]